Novo Nordisk and Mylan Battle Over Generic Versions of Victoza

Denmark’s Novo Nordisk filed a lawsuit in a Delaware district court against generic drugmaker Mylan. The suit is an attempt to block Mylan from marketing a generic version of Novo Nordisk’s diabetes drug Victoza (liraglutide).